1. Home
  2. XELB vs KAPA Comparison

XELB vs KAPA Comparison

Compare XELB & KAPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XELB
  • KAPA
  • Stock Information
  • Founded
  • XELB 2011
  • KAPA 2013
  • Country
  • XELB United States
  • KAPA United States
  • Employees
  • XELB N/A
  • KAPA N/A
  • Industry
  • XELB Multi-Sector Companies
  • KAPA
  • Sector
  • XELB Miscellaneous
  • KAPA
  • Exchange
  • XELB Nasdaq
  • KAPA NYSE
  • Market Cap
  • XELB 19.0M
  • KAPA 19.9M
  • IPO Year
  • XELB N/A
  • KAPA 2024
  • Fundamental
  • Price
  • XELB $0.51
  • KAPA $1.55
  • Analyst Decision
  • XELB
  • KAPA Strong Buy
  • Analyst Count
  • XELB 0
  • KAPA 1
  • Target Price
  • XELB N/A
  • KAPA $9.00
  • AVG Volume (30 Days)
  • XELB 359.0K
  • KAPA 64.3K
  • Earning Date
  • XELB 12-20-2024
  • KAPA 02-23-2025
  • Dividend Yield
  • XELB N/A
  • KAPA N/A
  • EPS Growth
  • XELB N/A
  • KAPA N/A
  • EPS
  • XELB N/A
  • KAPA N/A
  • Revenue
  • XELB $9,337,000.00
  • KAPA N/A
  • Revenue This Year
  • XELB N/A
  • KAPA N/A
  • Revenue Next Year
  • XELB $82.99
  • KAPA N/A
  • P/E Ratio
  • XELB N/A
  • KAPA N/A
  • Revenue Growth
  • XELB N/A
  • KAPA N/A
  • 52 Week Low
  • XELB $0.33
  • KAPA $1.22
  • 52 Week High
  • XELB $1.70
  • KAPA $4.00
  • Technical
  • Relative Strength Index (RSI)
  • XELB 43.26
  • KAPA N/A
  • Support Level
  • XELB $0.33
  • KAPA N/A
  • Resistance Level
  • XELB $0.53
  • KAPA N/A
  • Average True Range (ATR)
  • XELB 0.09
  • KAPA 0.00
  • MACD
  • XELB 0.01
  • KAPA 0.00
  • Stochastic Oscillator
  • XELB 43.27
  • KAPA 0.00

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain design, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

About KAPA KAIROS PHARMA LTD

Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.

Share on Social Networks: